Effect of size and dose on the biodistribution of graphene oxide in mice.
暂无分享,去创建一个
Yanli Chang | Aoneng Cao | Haifang Wang | Aoneng Cao | Sheng-Tao Yang | Jia-Hui Liu | Jia-Hui Liu | Sheng-Tao Yang | Haifang Wang | Yuanfang Liu | Yuanfang Liu | Yanli Chang
[1] Manuela Semmler-Behnke,et al. Biodistribution of 1.4- and 18-nm gold particles in rats. , 2008, Small.
[2] M. Prato,et al. Tissue histology and physiology following intravenous administration of different types of functionalized multiwalled carbon nanotubes. , 2008, Nanomedicine.
[3] Chunxin Zhang,et al. Significant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor models. , 2007, Nanomedicine : nanotechnology, biology, and medicine.
[4] Xin Wang,et al. Biodistribution of Pristine Single-Walled Carbon Nanotubes In Vivo† , 2007 .
[5] Yuehe Lin,et al. Aptamer/graphene oxide nanocomplex for in situ molecular probing in living cells. , 2010, Journal of the American Chemical Society.
[6] Dong Liang,et al. Influence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted mice. , 2009, Biomaterials.
[7] G. Wallace,et al. Mechanically Strong, Electrically Conductive, and Biocompatible Graphene Paper , 2008 .
[8] Huang-Hao Yang,et al. A graphene platform for sensing biomolecules. , 2009, Angewandte Chemie.
[9] Liangzhu Feng,et al. Graphene in biomedicine: opportunities and challenges. , 2011, Nanomedicine.
[10] M Ferrari,et al. Size and shape effects in the biodistribution of intravascularly injected particles. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[11] Kai Yang,et al. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. , 2010, Nano letters.
[12] Zhijun Zhang,et al. Functional graphene oxide as a nanocarrier for controlled loading and targeted delivery of mixed anticancer drugs. , 2010, Small.
[13] Robert Sinclair,et al. Particle size, surface coating, and PEGylation influence the biodistribution of quantum dots in living mice. , 2008, Small.
[14] M. Hummelgård,et al. Real time monitoring of the drug release of rhodamine B on graphene oxide , 2011 .
[15] Yaping Li,et al. In vivo biodistribution and urinary excretion of mesoporous silica nanoparticles: effects of particle size and PEGylation. , 2011, Small.
[16] Manuela Semmler-Behnke,et al. Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[17] T. Niidome,et al. The effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[18] Christine Allen,et al. In vivo fate of unimers and micelles of a poly(ethylene glycol)-block-poly(caprolactone) copolymer in mice following intravenous administration. , 2007, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[19] Xin Huang,et al. Multi-functionalized graphene oxide based anticancer drug-carrier with dual-targeting function and pH-sensitivity , 2011 .
[20] Sunil Kumar Singh,et al. Size distribution analysis and physical/fluorescence characterization of graphene oxide sheets by flow cytometry , 2011 .
[21] Chunhai Fan,et al. Distribution and biocompatibility studies of graphene oxide in mice after intravenous administration , 2011 .
[22] W. P. Thomas,et al. Pulmonary diagnostic techniques. , 1983, The Veterinary clinics of North America. Small animal practice.
[23] Zhuang Liu,et al. PEGylated nanographene oxide for delivery of water-insoluble cancer drugs. , 2008, Journal of the American Chemical Society.
[24] Keishiro Tomoda,et al. Biodistribution of colloidal gold nanoparticles after intravenous administration: effect of particle size. , 2008, Colloids and surfaces. B, Biointerfaces.
[25] Yanli Chang,et al. In vitro toxicity evaluation of graphene oxide on A549 cells. , 2011, Toxicology letters.
[26] Parag Aggarwal,et al. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. , 2009, Advanced drug delivery reviews.
[27] Ya‐Ping Sun,et al. Covalently PEGylated carbon nanotubes with stealth character in vivo. , 2008, Small.
[28] Rebekah Drezek,et al. In vivo biodistribution of nanoparticles. , 2011, Nanomedicine.
[29] Yuehe Lin,et al. Graphene and graphene oxide: biofunctionalization and applications in biotechnology , 2011, Trends in Biotechnology.
[30] B. Nemery,et al. Acute Toxicity and Prothrombotic Effects of Quantum Dots: Impact of Surface Charge , 2008, Environmental health perspectives.
[31] L. Kaminskas,et al. Dendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties. , 2011, Nanomedicine.
[32] Ya‐Ping Sun,et al. Carbon Dots as Nontoxic and High-Performance Fluorescence Imaging Agents. , 2009, The journal of physical chemistry. C, Nanomaterials and interfaces.
[33] C. D. Stevens,et al. The distribution of radioactive iodine in mice with and without tumor 1509la after injection of radioactive sodium iodide. , 1950, Cancer research.
[34] Haifang Wang,et al. Long-term accumulation and low toxicity of single-walled carbon nanotubes in intravenously exposed mice. , 2008, Toxicology letters.
[35] Z. Chai,et al. Acute toxicity and biodistribution of different sized titanium dioxide particles in mice after oral administration. , 2007, Toxicology letters.
[36] Zhuang Liu,et al. Nano-graphene oxide for cellular imaging and drug delivery , 2008, Nano research.
[37] L. Illum,et al. Human serum albumin as a probe for surface conditioning (opsonization) of block copolymer-coated microspheres. , 1992, Biomaterials.
[38] Chunhai Fan,et al. A Graphene Nanoprobe for Rapid, Sensitive, and Multicolor Fluorescent DNA Analysis , 2010 .
[39] Cui Tang,et al. Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. , 2010, Biomaterials.
[40] Z. Xiaoyong,et al. Biodistribution of co-exposure to multi-walled carbon nanotubes and graphene oxide nanoplatelets radiotracers , 2011 .
[41] Kai Yang,et al. In vivo pharmacokinetics, long-term biodistribution, and toxicology of PEGylated graphene in mice. , 2011, ACS nano.
[42] Zhuang Liu,et al. Graphene based gene transfection. , 2011, Nanoscale.
[43] K. Avgoustakis,et al. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. , 2001, International journal of pharmaceutics.
[44] Haifang Wang,et al. Advances in biodistribution study and tracing methodology of carbon nanotubes. , 2010, Journal of nanoscience and nanotechnology.
[45] S. Shrivastava,et al. Thrombus inducing property of atomically thin graphene oxide sheets. , 2011, ACS nano.
[46] Qing Huang,et al. Biodistribution and toxicity of nanodiamonds in mice after intratracheal instillation. , 2010, Toxicology letters.
[47] Huang-Hao Yang,et al. Using graphene to protect DNA from cleavage during cellular delivery. , 2010, Chemical communications.
[48] Mi-Hee Kim,et al. Behaviors of NIH-3T3 fibroblasts on graphene/carbon nanotubes: proliferation, focal adhesion, and gene transfection studies. , 2010, ACS nano.